Microbiome Market Analysis 2024-2033 : Forecast Market Size, Top Segments And Largest Region | Seres Therapeutics, Enterome Bioscience, Ferring Pharmaceuticals, Vedanta BioSciences, Second Genome Inc

"The microbiome market size has grown exponentially in recent years. It will grow from $0.57 billion in 2023 to $0.69 billion in 2024 at a compound annual growth rate (CAGR) of 20.2%. The growth in the historic period can be attributed to increased need for immunology, increasing collaborations, government initiatives, increased healthcare expenditure and growth in the number of healthcare facilities.

The microbiome market size is expected to see rapid growth in the next few years. It will grow to $1.24 billion in 2028 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to rise in healthcare expenditure, rising requirement for customized medicine, increasing funding, technological advances and rising prevalence of chronic diseases. Major trends in the forecast period include use of artificial intelligence for better analysis and to smooth the processes, strategic collaborations and agreements to broaden their product portfolios, boost revenues and establish category leadership, investing in 3d printing technology for more accurate information and increased efficiency, increasing the number of pipeline studies to develop microbiome therapeutics to treat different diseases, consider investing in the development of oncology microbiome therapeutics to maximize revenues, and considering nanotechnology for identifying low-abundant samples and to improve productivity, efficiency and accuracy of the precision technologies being used.

Market Overview -
Microbiome refers to a group of microbes that live in a certain habitat and include fungi, bacteria, and viruses. It is all of the bacteria, fungi, protozoa, and viruses' genetic material that dwells on and within the human body. The microbiome's bacteria also aid in digestion, immune system control, defence against disease-causing bacteria, and the production of vitamins like Vitamin K, which is required for blood clotting, and the B vitamins B12, thiamine, and riboflavin.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=3397&type=smp

Inflammatory Bowel Disease (IBD) Fuels Growth In The Microbiome Market
The increasing prevalence of inflammatory bowel disease (IBD) is a key factor driving the growth of the microbiome market going forward. Inflammatory bowel disease (IBD) refers to a group of chronic inflammatory disorders that affect the digestive tract, primarily the gastrointestinal (GI) tract the inflammatory bowel disease has placed a spotlight on the gut microbiome's role in the disease. This has led to a surge in research, diagnostics, and therapies focused on the microbiome, driving the microbiome market's growth. For instance, in February 2021, according to Temple Health, a US-based non-profit academic healthcare organization, over 1.6 million individuals in the United States are currently living with inflammatory bowel disease (IBD), and its prevalence is expected to increase in the coming years. Therefore, the increasing prevalence of inflammatory bowel disease (IBD) is expected to drive the growth of the microbiome market.

Competitive Landscape -
Major companies operating in the microbiome market report are Seres Therapeutics, Enterome Bioscience, Ferring Pharmaceuticals, Vedanta BioSciences, Second Genome Inc., Microbiotica, Rebiotix, Inc, Locus Biosciences, Osel Inc., Xbiome Co., Ltd, Microba Life Sciences, Biome Australia, Shoreline Biome, Leucine Rich Bio Pvt Ltd, BugSpeaks, KINS Co., Ltd, Yeda Research and Development Co. Ltd, China National Pharmaceutical Group Corporation, Atlas Biomed, BiomX Ltd, ImmuneBiotech Medical Sweden AB, MetaboGen AB, ADM Biopolis, Viome, PharmaBiome, NCCR Microbiomes, MaaT Pharma, Eligo Bioscience, T3 Pharmaceuticals, MicroBiome Therapeutics LLC, Second Genome, OpenBiome, Microbiome Insights Inc., lallemand Health Solutions, Mybiotics Pharma, DayTwo, Next Biosciences, ViThera Pharmaceuticals Inc., Inqaba Biotechnical Industries (Pty), SNIPR Biome, MyBiome

Rising Technological Advancements Propel Innovation In The Microbiome Market
The growing technological improvement is a major trend gaining popularity in the microbiome market. Major companies in the microbiome sector are focusing on developing advanced technology solutions for microbiomes. For instance, Seed, a new microbiome company, has introduced Probiotic and Prebiotic Daily Synbiotic for both females and males. The Daily Synbiotic Seed is the first to follow a microbe-system strategy with strain-specific advantages beyond digestive health such as cardiac safety, dermatological health, immune control, reproductive health, the integrity of the gut barrier, and oxidative stress.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report

Key Segments -
The microbiome market covered in this report is segmented
1) By Type: Bacteria, Archaea, Viruses, Other Microbiomes
2) By Product: Therapeutics, Diagnostics
4) By Technology: Genomics, Proteomics, Metabolomics
3) By End-Use: Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Other Diseases

Sub segments: Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Others, Genomics, Proteomics, Metabolomics

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.